The Ottawa Hospital's Biotherapeutics Manufacturing Centre (IMAGE)
Caption
The CanPRIME program, based at The Ottawa Hospital's Biotherapeutics Manufacturing Centre, is bolstering Canada's capacity to manufacture vaccines, viral immunotherapies for cancer and other emerging biotherapeutics.
Credit
The Ottawa Hospital
Usage Restrictions
Only for use with stories about The Ottawa Hospital's Biotherapeutics Manufacturing Centre.
License
Licensed content